• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    SC 13G/A 1 tv0226-aligntechnologyinc.htm SCHEDULE 13G/A aligntechnologyinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 12)*

    Name of issuer:  Align Technology Inc

    Title of Class of Securities:  Common Stock

    CUSIP Number:  016255101

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  016255101

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    96,637

    7.  SOLE DISPOSITIVE POWER

    8,037,726

    8.  SHARED DISPOSITIVE POWER

    311,885

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    8,349,611

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    10.90%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Align Technology Inc

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    410 North Scottsdale Road, Suite 1300
    Tempe, AZ 85288

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    016255101

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $ALGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    12/11/2023$197.00Neutral → Sell
    Goldman
    10/27/2023$200.00Buy → Neutral
    UBS
    More analyst ratings

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Align Technology Announces New $1 Billion Stock Repurchase Program

      Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has authorized a new stock repurchase program. Under the new program, Align may purchase up to $1.0 billion of its common stock over the next three years. The company's prior $1 billion authorization approved in January 2023 was completed on May 1, 2025 (with settlement on May 2, 2025). "We are pleased to announce that our Board of Directors has authorized a new $1 billion sto

      5/6/25 9:00:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Speak at Upcoming Financial Conferences

      Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month. Conference: Bank of America 2025 Healthcare Conference Date: Tuesday, May 13, 2025

      5/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/13/24 4:59:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/24 4:31:42 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/23 11:07:31 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann converted options into 3,341 shares and covered exercise/tax liability with 965 shares, increasing direct ownership by 51% to 7,068 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:47:20 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • EVP GLOBAL HR Hockridge Stuart A converted options into 2,587 shares and covered exercise/tax liability with 696 shares, increasing direct ownership by 20% to 11,558 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:46:27 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • EVP & CHIEF FINANCIAL OFFICER Morici John converted options into 4,539 shares and covered exercise/tax liability with 1,509 shares, increasing direct ownership by 23% to 16,023 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:45:47 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Align Tech downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

      4/25/25 8:29:20 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Wells Fargo initiated coverage on Align Tech with a new price target

      Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00

      2/14/25 7:02:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Tech upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously

      1/6/25 7:28:53 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    See more
    • Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

      Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

      3/25/25 4:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

      5/22/24 5:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

      2/8/23 4:55:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Financials

    Live finance-specific insights

    See more
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Announce First Quarter 2025 Results on April 30, 2025

      Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

      4/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces Fourth Quarter and Fiscal 2024 Financial Results

      Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA

      2/5/25 4:05:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    SEC Filings

    See more
    • SEC Form 10-Q filed by Align Technology Inc.

      10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/8/25 5:14:03 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/6/25 9:00:29 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      4/30/25 4:06:37 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      8/19/24 6:35:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,845 worth of shares (5,194 units at $192.50), increasing direct ownership by 3% to 208,664 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/9/23 8:35:10 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,972 worth of shares (5,319 units at $188.00), increasing direct ownership by 3% to 203,470 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/1/23 5:18:50 PM ET
      $ALGN
      Industrial Specialties
      Health Care